Research on the mechanisms of ageing has identified ways via which lifespan can 13 be extended in model organisms, increasing the potential for translation of these 14 findings to our own species. However, the large majority of research on animal 15 models involves dietary, genetic or pharmacological treatments throughout life -16 limiting translational potential and ignoring age-dependent effects. Previously, we 17 have suggested using demographic meta-analysis that reduced mTor signalling has 18 the potential to instantly rejuvenate. We have now tested this prediction 19 experimentally using large-scale demographic data (N > 10,000) combined with 20 conditional knockdown of mTor in Drosophila melanogaster. Indeed, reduced mTor 21 decreased mortality rate when applied during old age. Interestingly, we found that 22 transient treatment during early adult life had long-lasting benefits. Age-dependent 23 deep-RNAseq indicated that these effects arose from distinct physiology and 24 implicate alternative splicing as a potential mechanism for the long-lasting benefits of 25 transient mTor reduction. These findings suggest that reducing mTor short term or 26 during old age could be used to combat ageing. In addition, our findings suggest that 27 the results from experimental research on mTor signalling, and potentially other 28 mechanisms of ageing, that employ life-long interventions are likely to be a complex 29 composite of age-dependent effects that counteract or enhance each other. 30 157 effects cox proportional hazard models correcting for cage effects (see methods 14,31 ). B) Transient 158 mTor knockdown (maximum induction of GeneSwitch at blue dotted line) resulted in a modest 159 increase in mortality during early life, but subsequently resulted in a sustained mortality reduction 160 throughout life (P < 0.0001). Similar effects were seen when mTor was knocked down continuously.
Introduction 31
The biology of ageing field has progressed our understanding of mechanisms and 32 interventions that can extend health-and lifespan. The most potent and researched 33 of these are dietary restriction 1-3 and reducing mTor (mechanistic Target of 34 Rapamycin) signalling 4-6 . These interventions we now (only) partially understand and 35 there is a growing wish and reality for translation to our own species 7 . A key factor 36 that hinders the translation of these findings to humans is however that the large 37 majority of the experiments in animal models are carried out for their entire lifetimes, 38 which begs the question whether long-term treatment will be required in humans as 39 well. Any long-term treatment will be hard to apply in our own species and close to 40 impossible to study in clinical trials. More immediate benefits to health-and lifespan 41 are sought for to hold translational promise 8, 9 . Notably, dietary restriction can have 42 instant benefits on health indicators 2,10 , but trials in humans have only been 43 conducted over a relatively short timespan 10, 11 . Animal experiments have shown that 44 in terms of longevity, mortality risk is instantly modulated by diet in flies 12-14 , but 45 experiments in other organisms, namely rodents suggest late-life treatment is not 46 necessarily pro-longevity 15, 16 . In contrast, short-term energy restriction in early life 47 can result in long-lasting health benefits, as for example in mice by restricting milk 48 access 17 . 49
Reduced mTor signalling has now also been suggested to improve life expectancy 51 after short-term treatment or in old animals. Rapamycin treatment from 600 days of 52 age onwards resulted in longevity benefits (especially in females, as control biased 53 mortality occurred prior to drug treatment in males) 9 . Recently, short term transient 54 rapamycin treatment (of 3 months) of mice aged 2 years led to a lifespan extension, 55 but the authors acknowledge sample size for this study is limited 18 . We have recently 56 also argued using demographic meta-analysis across four model species that 57 reducing mTor signalling at old age could reduce mortality risk 4 . Such inference from 58 demographic models can be informative 4, 15, 16, 19, 20 , but only by testing different ages 59 of manipulation can such demographic patterns be tested for causality 8, 12, 13, 21 . Here, 60
we present the first of such comprehensive evidence using large-scale demography 61 comprising over 10,000 individual flies (Drosophila melanogaster) , showing that 62 reduction of mTor in late life results in instant benefits on life expectancy. In addition, 63 we find that short transient mTor knockdown during early adulthood has long-lasting 64 benefits reducing mortality in late life even when mTor levels are back to 65 unmanipulated levels. Age-dependent RNAseq data from this experiment showed 66 that these two effects originate from differential physiology, potentially derived from 67 differences in alternative splicing. 68
Results and discussion 70

Experimental design and GeneSwitch kinetics 71
Age-dependent knockdown of mTor (using in vivo RNAi 22 ) was achieved using the 72 well-established conditional GeneSwitch system 23,24 , by feeding adult flies 73 mifepristone (RU486). We chose RNAi over rapamycin treatment as genetic 74 suppression of mTor signalling results in larger effects 4 and more potent rapalogs 75 are currently being developed 25 Figure 1 ). This age-dependent treatment regime was chosen based on an initial 82 experiment measuring age-specific mortality in response to whole life mTor 83 knockdown, as well as a lower sample size experiment that showed mTor 84 knockdown in late life reduced mortality (both unpublished). 85
86
Control experiments confirmed there were no age-dependent changes in the 87 inducibility of the GeneSwitch system (e.g. due to differential feeding or metabolism 88 of RU486) and determined the kinetics of GeneSwitch induction and termination 89 upon RU feeding. With daughterless GeneSwitch (da-GS, expressed in the whole 90 fly) 23 crossed to overexpression constructs of hid and reaper (inducers of cell 91 death 26 ), we drove and measured the corresponding impact on death relative to RU 92 feeding. Irrespective of age of induction, mortality started to rise after about 2-4 days 93 after initial RU feeding, reached maximum induction after 12 days of RU feeding, and 94 returned to control levels after about 12 day once RU feeding was terminated ( Figure  95 2A, P < 0.0001, N = 3,287). These RU induction dynamics were used to interpret the 96 kinetic effects of mTor knockdown on mortality and transcriptional profiles ( Figure 1) . 97 
104
Negative Control 105
Although no confounding effects of RU486 on mortality have been reported in similar 106 experiments 23,27-30 we conducted negative controls to exclude any such effects. The 107 da-GS driver line was crossed to a genetic control from the TRiP collection that 108 included the insertion vector without shRNA. Offspring of this cross were studied 109 directly alongside the kinetic control and age-dependent knockdown experiments. 110
When RU486 was applied in the same regime as all induction experiments, no 111 difference in mortality was seen among any treatment ( Figure 2B to distil transcriptional changes that are uniquely associated with the different age-172 dependent treatment regimes of mTor RNAi (Figure 1 ). We plotted these effects on 173 the KEGG mTor network to visualize these differences. Knockdown of mTor in late 174 life produced only a limited response across the whole network, whereas transient 175 knockdown in early life induced persistent, substantial differential expressed across 176 the network even though mTor expression was back at control levels ( Figure S1 ). 177
In the early, transient mTor knockdown cohort, over 6,000 of 10,187 identified 178 transcripts were statistically differentially expressed when compared at old age 179 (model comparison second sampling point at 39 days old, after false-discovery rate 180
Benjamini-Hochberg correction) ( Figure 5 ). Continuous knockdown resulted in over 181 2,000 differentially expressed genes, whereas late life knockdown resulted in limited 182 differential transcription of around 700 genes. Note, that the comparisons of interest 183 statistically identified here are the additional contribution of the timing of mTor 184 knockdown (early versus late) on top of any effects of whole life knockdown 185 compared to control (for statistical framework see methods). Remarkably, there was 186 only limited overlap in altered transcripts among the treatment categories suggesting 187 the age-dependent effects of mTor knockdown were distinct rather than additive 188 ( Figure 5 ). 189 
Age-dependent reduction of mTor signalling implicates different physiology 206
We performed directional KEGG and GO enrichment analyses 32 to provide a 207 generalised view of physiological changes between the transcriptional responses 208 across the three distinct timings of mTor knockdown compared to control (Tables S1-209 S6). Divergent processes were associated with each of the three timing regimes of 210 mTor reduction. 211
212
Whole life mTor reduction was associated with upregulated sugar-based metabolism 213 and amino-acid metabolism (Table S1 ). In contrast to previous studies where mTor 214 suppression upregulates protein processing and the proteasome 33,34 , reduced mTor 215 here downregulated these protein degradation pathways. Variation in temporal 216 dynamics may explain these differences: when the cell is starved it will activate 217 autophagy and protein degradation related mechanisms, but once excess proteins 218 are recycled, the resultant effect is a downregulation of the protein recycling 219 machinery and a shift in total metabolism. The conclusion of the effects of reduced 220 mTor signalling on protein processing and the proteasome might therefore depend 221 on the timing after which this is measured and may depend on the system in which 222 this is studied: cell culture versus whole organism, but this interpretation will require 223 future testing. In line with the interpretation that metabolism is downregulated when 224 mTor is reduced for a prolonged time is that DNA replication and RNA transport are 225 downregulated (Table S1) . 226
In contrast to continuous mTor knockdown, transient depletion of mTor in early adult 227 life upregulated cellular activity at terms representing DNA replication, RNA transport 228 and basal transcription factors, and for ubiquitin mediated proteolysis at old age. 229
Lysosome-associated terms are downregulated as are as elements for metabolism, 230 mainly related to fats (Table S2 ). We find terms for the spliceosome are widely 231 upregulated, which may explain why transient mTor knockdown has systemic long-232 term effects on mortality rate and gene expression (Table S2) . Notably, work with C. 233 elegans recently suggests that splicing regulation is a potential key mediator of 234 ageing during dietary restriction and by control of mTor [35] [36] [37] [38] . We detected limited 235 KEGG enrichment with genes uniquely differentially expressed in the late life mTor 236 knockdown regime suggesting these effects are similar to knockdown of mTor 237 throughout life. Of note, is the partial downregulation of the spliceosome (15 out of 238 115 genes in this category, Table S3 ) compared to upregulation in the transient 239 mTor knockdown treatment (84 out of 115). These interpretations based on KEGG 240 were likewise seen in GO analysis, although at lower resolution (Tables S4-S6) . 241
Alternative splicing 242
Noting that the spliceosome was upregulated in the transient mTor group, we 243 analysed the RNAseq data set for alternative splicing using exon-level based reads. 244
In the transient mTor knockdown group, 327 genes were significantly differentially 245 spliced, compared to 17 of continuous mTor knockdown and 4 specific to mTor 246 knockdown in late life. KEGG analysis in the transient mTor knockdown group were 247 enriched for differentially spliced variants associated with endocytosis 39 , the 248 lysosome 40 , Hippo signalling (potentially mediating longevity through autophagy 41 249 and FOXO 42 ) and mTor signalling itself (Table S7) Short-term treatments that extend lifespan will be key to translate findings from the 257 field of ageing biology to actual medical applications. These experiments provide the 258 evidence, together with earlier findings from late-life and transient treatment with 259 rapamycin (inhibitor of mTor) in mice 9,18 , that short-term or timed suppression of 260 mTor signalling can have beneficial effects on life/health-span 4 -a treatment regime 261 that might be practical for humans. While the magnitude of reduced mortality 262 produced by mTor inhibition are less than those we report for diet restriction in 263 These novel insights will help inform future application and potential side effects of 272 drugs targeting mTor. Future work will benefit from uncovering if tissue-specific 273 effects of mTor signalling underlie these age-dependent dynamics and will also need 274
to experimentally test which physiological mechanisms hypothesised from the 275 transcriptome profiles cause the observed mortality differences. These mechanisms 276 will be complex because our data suggest that reduced mTor throughout life 277 probably affects a composite of two (or more) age-dependent processes. 278
Methods 279
Fly husbandry and mortality measurement 280
Flies were grown and kept on our standard rich diet (8% autolysed yeast, 13% table  281 sugar, 6% cornmeal, 1% agar and nipagin 0. 
Statistical analysis of mortality 301
All mortality data was analysed using mixed effects cox-proportional hazard models 302 using age-dependent covariates 46 to test for the age-dependent changes in mortality. 303
These models are conservative as they correct for pseudoreplication cause by cage 304 effects (similar to vial to vial error and critical in reducing type I error). Age-305 dependent covariates allow a comparison during specific ages, specifically relevant 306 as the experimental design induced age-dependent modulation of mTor (Figure 1) 14 . 307
Coefficients are reported in the text and are in comparison to the control treated flies. 308
These coefficients are shown on the linear scale, with standard errors on the log-309 scale to maintain symmetric errors. Models also included transfer day in the model to 310 correct for any variation between day or growing conditions (although omission of 311 this correction did not change any of the results). All experiments had a maximum of 312 four transferring days into the cages and ages at RU486 treatment thus maximally 313 differed 1-2 days around the mean age of induction. The x-axis, age, in the raw 314 mortality graphs is corrected for such differences in transfer data as all flies (across 315 all the data presented) were given RU486 on the same calendar date. In the graphs 316 this allows an appreciation of the changes in mortality in response to RU486 timing. 317
All analyses included actual non-corrected ages. using annotated (and thus not de novo assembled) transcripts using hisat2 47 , 328 formatted into read counts using stringtie 47 to be used in ballgown 47 in R, and 329 analysed for differential expression using edgeR using the general linear modelling 330 framework in glmQLFit. We used a full model design correcting for age-dependent 331 changes of mTor knockdown to distil the effects of the timing regimes specifically at 332 late age on the total transcriptome (y ~ knockdown * timepoint + timing regime at old 333 age). This statistical framework therefore identifies differential transcription specific 334 to the timing regime by which mTor is conditionally knocked down compared to 335 control conditions when mortality benefits where observed (Figure 3 ). Differential 336 splicing was analysed using exome mapping and the function diffSpliceDGE from 337 edgeR. KEGG and GO enrichments 32 were conducted using the limma 48 package in 338 R. For plotting of the KEGG mTor pathway, the pathway was updated manually 339 using the most recent fly literature for plotting purposes only (but not for enrichment 340 analyses). 
